AtlasXomics

AtlasXomics, a 2020 Yale spin-out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases.

AtlasXomics

AtlasXomics, a 2020 Yale spin-out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. This innovative platform, called “Deterministic Barcoding in Tissue for spatial-omics sequencing” (DBiT-seq), was developed by Dr. Rong Fan, Professor of Biomedical Engineering at Yale University. DBiT-seq leverages microfluidics and next generation sequencing (NGS) to create transformative multi-omic maps (proteomics, transcriptomics, and epigenomics) in tissue at cellular resolution, unlocking information about interactions between cells in localized neighborhoods. The platform was published in Cell in 2020 and Science in 2022. AtlasXomics is the first spatial company to offer spatial ATAC-seq and spatial CUT & Tag for mapping chromatin accessibility and histone modifications across the entire genome in tissue